Differential effects of pea protein isolate, pea protein concentrate, and whey protein isolate supplementation on gut microbiota and metabolic markers in healthy adults: a 3-arm parallel randomised intervention
4 affiliations
- 1School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
- 2Food and Health Centre, Örebro University, Örebro, Sweden
- 3School of Science and Technology, Faculty of Business, Science and Engineering, Örebro University, Örebro, Sweden
- 4Clinical Genomics Örebro, Science for Life Laboratory, Örebro University, Örebro, Sweden
Abstract
Purpose: As origin and quality of dietary protein are key modulators of gut microbiota and host metabolism, characterising health effects of different proteins is increasingly important given the need to shift towards more plant-based protein sources for environmental sustainability. Yet, direct comparisons across protein sources and food matrices in humans remain limited. This randomised, double-blind, 3-arm parallel, dietary intervention study examined the effects of four-week pea protein concentrate (PPC), pea protein isolate (PPI) or whey protein isolate (WPI) supplementation (0.5 g/kg body mass/day) on gut microbiota composition in healthy adults as the main outcome.
Methods: Faecal samples and lifestyle questionnaires were collected weekly, with fasting blood and 24-h urine samples obtained at baseline, mid- and post-intervention. Proteins were compared using two contrasts – PPC vs. PPI and PPI vs. WPI – investigating differences between plant and animal-based proteins as well as between plant-based proteins with different matrixes.
Results: Supplementation of PPC and PPI significantly reduced α-diversity and increased β-diversity, partly modulated by BMI. At species level, relative abundances of Anaerobutyricum hallii and Bifidobacterium longum increased significantly in subjects consuming PPC. A similar result was observed for Lactobacillus crispatus and Limosilactobacillus frumenti in subjects consuming PPI.
Conclusion: Our findings demonstrate that different dietary proteins selectively modulate beneficial gut microbial species, highlighting the importance of investigating individual responses to dietary interventions. Further studies are needed to verify how compositional changes translate into changes in microbial functionality.
Trial registration: This study is registered at www.clinicaltrials.gov as NCT05611138 (November 02, 2022).
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00394-026-04143-z.
Related
- An exploratory 12-week pilot study of gut microbiota and body-weight patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in Wistar rats.
- Effects of termitarium soil supplementation on fecal microbiota and fecal short-chain fatty acid profiles in captive Chinese pangolins (Manis pentadactyla)
- Postoperative inulin supplementation is associated with microbiota remodeling and improved colonic anastomotic healing in LPS-primed mice
- Effects of faecal microbiota transplantation on glycaemic outcomes in adults with metabolic disorders: a systematic review and meta-analysis of randomised controlled trials
- Gut microbiota-immune-bone axis in osteoporosis: mechanisms and intervention strategies
BibTeX
@article{kamm2026differential,
title = {{Differential effects of pea protein isolate, pea protein concentrate, and whey protein isolate supplementation on gut microbiota and metabolic markers in healthy adults: a 3-arm parallel randomised intervention}},
author = {Annalena Kamm and Samira Prado and Katharina Dannenberg and Dirk Repsilber and Tatiana M. Marques and Robert J. Brummer},
journal = {European Journal of Nutrition},
year = {2026},
month = nov,
doi = {10.1007/s00394-026-04143-z},
url = {https://doi.org/10.1007/s00394-026-04143-z},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Differential effects of pea protein isolate, pea protein concentrate, and whey protein isolate supplementation on gut microbiota and metabolic markers in healthy adults: a 3-arm parallel randomised intervention
AU - Annalena Kamm
AU - Samira Prado
AU - Katharina Dannenberg
AU - Dirk Repsilber
AU - Tatiana M. Marques
AU - Robert J. Brummer
PY - 2026
DA - 2026/11/11
JO - European Journal of Nutrition
DO - 10.1007/s00394-026-04143-z
UR - https://doi.org/10.1007/s00394-026-04143-z
AB - Purpose: As origin and quality of dietary protein are key modulators of gut microbiota and host metabolism, characterising health effects of different proteins is increasingly important given the need to shift towards more plant-based protein sources for environmental sustainability. Yet, direct comparisons across protein sources and food matrices in humans remain limited. This randomised, double-blind, 3-arm parallel, dietary intervention study examined the effects of four-week pea protein concentrate (PPC), pea protein isolate (PPI) or whey protein isolate (WPI) supplementation (0.5 g/kg body mass/day) on gut microbiota composition in healthy adults as the main outcome. Methods: Faecal samples and lifestyle questionnaires were collected weekly, with fasting blood and 24-h urine samples obtained at baseline, mid- and post-intervention. Proteins were compared using two contrasts – PPC vs. PPI and PPI vs. WPI – investigating differences between plant and animal-based proteins as well as between plant-based proteins with different matrixes. Results: Supplementation of PPC and PPI significantly reduced α-diversity and increased β-diversity, partly modulated by BMI. At species level, relative abundances of Anaerobutyricum hallii and Bifidobacterium longum increased significantly in subjects consuming PPC. A similar result was observed for Lactobacillus crispatus and Limosilactobacillus frumenti in subjects consuming PPI. Conclusion: Our findings demonstrate that different dietary proteins selectively modulate beneficial gut microbial species, highlighting the importance of investigating individual responses to dietary interventions. Further studies are needed to verify how compositional changes translate into changes in microbial functionality. Trial registration: This study is registered at www.clinicaltrials.gov as NCT05611138 (November 02, 2022). Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00394-026-04143-z.
SN - 1436-6207
SN - 1436-6215
ER -